
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment
Pharmaceutical Executive
00:00
Regeneron–Tessera $150M Gene Editing Deal
Unknown Host reports on Regeneron's $150 million collaboration with Tessera to advance RNA-based gene writing platforms.
Play episode from 00:30
Transcript


